BioXPass is pioneering personal bio defense — a new category of protection that safeguards individuals against biological threats through proprietary detection, identification, and countermeasure technologies applicable across enterprise security, government operations, and high-net-worth personal protection.

BioXPass addresses a critical and emerging need — personal biological defense for individuals and organizations operating in high-risk environments. The technology provides real-time bio threat detection, identification, and protective countermeasures.

The platform serves three core markets: enterprise security programs protecting executive personnel and critical facilities, government and defense agencies requiring field-deployable bio defense capabilities, and elite individuals seeking best-in-class personal protection against biological threats.

Venture Capricorn’s involvement brings strategic M&A expertise, defense sector relationships, and institutional capital connections that position BioXPass for accelerated market penetration across government contracting channels and enterprise security procurement.